High drug prices smiling medical technology company?

Has become a problem of high drug prices from the United States government to the people have a headache. To solve this problem, up and down the US government have put forward their point of view. Even drug prices problem has also become an important part of the US presidential election, Hillary Clinton in September this year, will once declared war high drug prices. For a time, the whole bio-pharmaceutical sector has suffered a significant impact. However, a boycott of the sound, medical technology companies and medical device companies can become a potential gainers.
Reuters reported that in the past few months, with Edwards Lifesciences, Boston Scientific and Becton Dickinson as the representative of the medical technology company on the stock's performance has gone beyond the average level of bio-pharmaceutical companies. September this year, Hillary Clinton a "declaration of war to high drug prices," the tweets to continue to push stock prices biomedical industry market poured cold water. In a few months time, the Nasdaq stock index has fallen biomedical exceed 5 percent. Thus, many analysts analysts believe medical device company stocks have better biological pharmaceutical stocks.
However, there are still some people have different views, the first medical device company optimistic about the market and a number of factors. Chief among them is the size of the elderly population increases due to increased market demand. Second, emerging market development so that the company's business began to increase significantly. Moreover, with high drug prices in stark contrast to recent years, medical equipment prices have been showing flat to down trend. Statistics 2008 --2014 years, many popular brands of drug prices rose twice as much. The price of medical devices places 2% -3% of the price decline year.
On the other hand, some analysts believe that the threat of high drug prices for pharmaceutical companies is far less serious than imagined. Albion Financial Group analyst on that although the prices of medicines caused by the nationwide discussion, but the company still tend to choose those with a groundbreaking new drugs pharmaceutical companies as potential investment targets. The best example is a new generation of hepatitis C drugs have been developed pharmaceutical giant Gilead.